 SEOUL, South KoreaBUSINESS WIREGenexine KOSDAQ: 095700, a publicly traded, clinical-staged Korean biopharmaceutical company committed to the discovery and development of novel biologics for the treatment of unmet medical needs, today announced it received Fast Track Designation FTD from the Korean Ministry of Food and Drug Safety MFDS for GX-188E tirvalimogene teraplasmid, its first-in-class proprietary therapeutic ...... 